Previous Close | 9.09 |
1-Year Change | 61.17% |
6-Months Change | 65.57% |
3-Months Change | 108.01% |
Moving Avg (50d) | 7.53 |
Moving Avg (200d) | 5.8863 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.2B |
Beta (3-Years) | 0.79 |
Revenue Growth (ttm) | 3201.48% |
Net Profit Margin (ttm) | -91.38% |
Return On Assets (ttm) | -61.67% |
EPS (ttm) | -0.56 |
PE Ratio (ttm) | -16.23 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |